FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/22/2024
Back to search
Official data from USPTO
MS BIOZONE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
01/22/2024
Classification
Registered
Trademark type
Word
Nice classes
41
Filing date
09/15/2022
Registration date
08/22/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/22/2023
Last transaction
08/22/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
CH
Examiner
BETTS, MARCYA
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Sandoz AG
Novartis AG
Representatives
Maury M. Tepper, III Tepper & Eyster, PLLC
Technical classification
Nice Classes
Class 41
Vienna Codes
No Vienna codes available.
Goods and services
Class 41
Organization and conducting of seminars with respect to biosimilar medicine and neurology; organization and conducting of conferences with respect to biosimilar medicine and neurology; organization and conducting of congresses with respect to biosimilar medicine and neurology; organization and conducting of symposiums with respect to biosimilar medicine and neurology; organization and conducting of workshops with respect to biosimilar medicine and neurology; organization and conducting of training and further training courses with respect to biosimilar medicine and neurology; providing continuing medical education courses with respect to biosimilar medicine and neurology
Publications
History of USPTO decisions and trademark events.
27 publications found
CHLD
CHANGE OF OWNER RECEIVED FROM IB
01/19/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/28/2023
FIMP
FINAL DISPOSITION PROCESSED
11/28/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/22/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/22/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
08/22/2023
GPNX
NOTIFICATION PROCESSED BY IB
06/06/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/06/2023
PUBO
PUBLISHED FOR OPPOSITION
06/06/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/17/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
05/17/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/17/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/01/2023
RFNT
REFUSAL PROCESSED BY IB
04/13/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/06/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/06/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/06/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/21/2023
RFRR
REFUSAL PROCESSED BY MPU
03/21/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/26/2023
CNRT
NON-FINAL ACTION WRITTEN
01/25/2023
DOCK
ASSIGNED TO EXAMINER
01/18/2023
MAFR
APPLICATION FILING RECEIPT MAILED
11/26/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/22/2022
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
11/17/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/10/2022
Continuous trademark protection
Get notified about every new filing that threatens MS BIOZONE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.